Mologen AG

Industry · 5 registered clinical trials.

Status	Trial	Phase	Started
Unknown	Evaluation of MGN1703 Maintenance Treatment in Patients With mCRC With Tumor Reduction During Induction Treatm Metastatic Colorectal Cancer	Phase 3	2014-09-01
Completed	Randomized Study of Maintenance Therapy With MGN1703 in Patients With SCLC Small Cell Lung Cancer	Phase 2	2014-03-01
Completed	A Phase I Study to Assess Cardiac and General Safety and Pharmacokinetics of 60 mg MGN1703 Healthy	Phase 1	2013-11-01
Completed	A Clinical Study to Assess Safety and Efficacy of a Tumor Vaccine in Patients With Advanced Renal Cell Carcino Stage IV Renal Cell Cancer	Phase 1 / Phase 2	2010-11-01
Completed	Efficacy Study of a Maintenance Therapy With Immunomodulator MGN1703 in Patients With Advanced Colorectal Carc Advanced Colorectal Carcinoma	Phase 2	2010-06-01